About Auxilius
Auxilius is a B2B SaaS platform purpose-built for biopharma finance and accounting teams managing clinical trial costs. The platform automates budgeting, forecasting, accruals, and financial close processes by integrating clinical, financial, and contractual data into a single source of truth. It serves 100+ biopharma companies—ranging from emerging biotechs to large pharma—managing over $15B in R&D spend.
Company details
Funding
Total raised
$20M
Last stage
Series A
Investors
Founders
Erin Warner Guill
President and COO of Auxilius, co-leading the company alongside Adam Weisman since its founding in 2020.
LinkedIn
Adam Weisman
Co-founder and CEO of Auxilius. Previously operated and invested in early-stage product and data businesses at the intersection of technology and healthcare at Redstar Ventures, IndUS Growth Partners, and DRG.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.